FDA Issues New Warning for Two Diabetes Medications
Drugs containing saxagliptin or alogliptin may be linked to heart failure risk
Hydromorphone May Be New Treatment for Heroin Addiction
Researchers find hydromorphone an effective, widely available, licensed choice
FDA Approves Inflectra as ‘Biosimilar’ to Remicade
For adults with Crohn's, rheumatoid arthritis, or psoriasis
ACC: Rate, Rhythm Control Both Effective for Post-Op A-Fib
Equal number of days of hospitalization, similar complication and persistent a-fib rates
ACC: Pre-pPCI Metoprolol Doesn’t Reduce Infarct Size in STEMI
Metoprolol cut incidence of malignant arrhythmias; was not linked to increase in adverse events
ACC: Pharmacist Intervention Can Cut Cardiovascular Risk
Twenty-one percent decrease in CVD risk after adjustment for baseline values, center effect
ACC: Vitamin D Found to Improve Cardiac Function in Heart Failure
Further studies necessary to determine whether this translates to improvements in outcomes
The Endocrine Society, April 1-4
The Endocrine Society's 98th Annual Meeting & Expo The annual meeting of The Endocrine Society (ENDO 2016) was held from April 1 to...
Intraarterial Chemo + Radiation May Up Cerebral Infarctions
Findings from comparison with intravenous chemoradiotherapy
ACC: Losmapimod Doesn’t Cut Cardio Events After Acute MI
In part A of trial, no reduction in risk of composite of cardiovascular death, MI, severe recurrent ischemia
